660 related articles for article (PubMed ID: 18676265)
1. [Cell-free fetal DNA detection in maternal plasma using real-time PCR and cycling probe technology for prenatal screening beta-thalassaemia major].
Chen X; Ren JH; Guo H; Lin LH; Yao QX
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1210-3. PubMed ID: 18676265
[TBL] [Abstract][Full Text] [Related]
2. Prenatal detection of beta-thalassemia CD17 (A-->T) mutation by polymerase chain reaction/ligase detection reaction/capillary electrophoresis for fetal DNA in maternal plasma--a case report.
Yi P; Chen Z; Yu L; Zheng Y; Xie H; Zheng X; Liu Q; Han J; Li L
Fetal Diagn Ther; 2010; 27(1):25-31. PubMed ID: 19955703
[TBL] [Abstract][Full Text] [Related]
3. Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E-beta-thalassemia.
Tungwiwat W; Fucharoen G; Fucharoen S; Ratanasiri T; Sanchaisuriya K; Sae-Ung N
Transl Res; 2007 Nov; 150(5):319-25. PubMed ID: 17964521
[TBL] [Abstract][Full Text] [Related]
4. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations.
Li Y; Holzgreve W; Hahn S
Methods Mol Biol; 2008; 444():239-51. PubMed ID: 18425486
[TBL] [Abstract][Full Text] [Related]
5. [Prenatal gene diagnosis of paternally inherited alpha-thalassemia by detecting fetal DNA in maternal plasma].
Chen P; Li MJ; Li MQ; Li SQ; Zhou LY; Lin WX
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1540-4. PubMed ID: 17785106
[TBL] [Abstract][Full Text] [Related]
6. [Prenatal diagnosis of β-thalassaemia using cell-free fetal DNA in maternal plasma].
Li GH; Rong KB; Luo YF; Chen D; Gong CP; Wu J; DI YW; Ge YF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1437-9. PubMed ID: 21868341
[TBL] [Abstract][Full Text] [Related]
7. Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry.
Li Y; Di Naro E; Vitucci A; Grill S; Zhong XY; Holzgreve W; Hahn S
Fetal Diagn Ther; 2009; 25(2):246-9. PubMed ID: 19506384
[TBL] [Abstract][Full Text] [Related]
8. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of beta-thalassaemia by reverse dot-blot hybridization.
Winichagoon P; Saechan V; Sripanich R; Nopparatana C; Kanokpongsakdi S; Maggio A; Fucharoen S
Prenat Diagn; 1999 May; 19(5):428-35. PubMed ID: 10360511
[TBL] [Abstract][Full Text] [Related]
10. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
11. Development of a PCR/LDR/capillary electrophoresis assay with potential for the detection of a beta-thalassemia fetal mutation in maternal plasma.
Yi P; Chen Z; Yu L; Zheng Y; Liu G; Xie H; Zhou Y; Zheng X; Han J; Li L
J Matern Fetal Neonatal Med; 2010 Aug; 23(8):920-7. PubMed ID: 20121392
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis of beta-thalassaemia and sickle cell anaemia in Turkey.
Tüzmen S; Tadmouri GO; Ozer A; Baig SM; Ozçelik H; Başaran S; Başak AN
Prenat Diagn; 1996 Mar; 16(3):252-8. PubMed ID: 8710780
[TBL] [Abstract][Full Text] [Related]
14. Prenatal control of severe thalassaemia: Chiang Mai strategy.
Tongsong T; Wanapirak C; Sirivatanapa P; Sanguansermsri T; Sirichotiyakul S; Piyamongkol W; Chanprapaph P
Prenat Diagn; 2000 Mar; 20(3):229-34. PubMed ID: 10719327
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive prenatal exclusion of haemoglobin Bart's using foetal DNA from maternal plasma.
Ho SS; Chong SS; Koay ES; Ponnusamy S; Chiu L; Chan YH; Rauff M; Baig S; Chan J; Su LL; Biswas A; Hahn S; Choolani M
Prenat Diagn; 2010 Jan; 30(1):65-73. PubMed ID: 19960446
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive prenatal diagnosis of beta-thalassaemia using individual fetal erythroblasts isolated from maternal blood after enrichment.
Kolialexi A; Vrettou C; Traeger-Synodinos J; Burgemeister R; Papantoniou N; Kanavakis E; Antsaklis A; Mavrou A
Prenat Diagn; 2007 Dec; 27(13):1228-32. PubMed ID: 17987605
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of beta-thalassemia in Egypt: implementing accurate high-tech methods did not reflect much on the outcome.
Elgawhary S; Elbaradie Sahar MY; Rashad WM; Mosaad M; Abdalla MA; Ezzat G; Wali YA; Elbeshlawy A
Pediatr Hematol Oncol; 2008 Sep; 25(6):541-8. PubMed ID: 18728973
[TBL] [Abstract][Full Text] [Related]
18. New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma.
Bustamante-Aragones A; Gallego-Merlo J; Trujillo-Tiebas MJ; de Alba MR; Gonzalez-Gonzalez C; Glover G; Diego-Alvarez D; Ayuso C; Ramos C
J Cyst Fibros; 2008 Nov; 7(6):505-10. PubMed ID: 18573697
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis and control strategies for beta-thalassaemia on the Indian subcontinent.
Varawalla NY
Natl Med J India; 1992; 5(4):157-61. PubMed ID: 1304300
[TBL] [Abstract][Full Text] [Related]
20. Multiplex fluorescent PCR for noninvasive prenatal detection of fetal-derived paternally inherited diseases using circulatory fetal DNA in maternal plasma.
Tang DL; Li Y; Zhou X; Li X; Zheng F
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):35-9. PubMed ID: 19285775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
